Kamil Ali-Jackson

2021

In 2021, Kamil Ali-Jackson earned a total compensation of $4.7M as Former Chief Legal Officer at Aclaris Therapeutics, a 511% increase compared to previous year.

Compensation breakdown

Option Awards$1,606,689
Salary$391,400
Stock Awards$683,304
Other$2,005,713
Total$4,687,106

Ali-Jackson received $2M in other compensation, accounting for 43% of the total pay in 2021.

Ali-Jackson also received $1.6M in option awards, $391.4K in salary and $683.3K in stock awards.

Rankings

In 2021, Kamil Ali-Jackson's compensation ranked 2,820th out of 12,415 executives tracked by ExecPay. In other words, Ali-Jackson earned more than 77.3% of executives.

ClassificationRankingPercentile
All
2,820
out of 12,415
77th
Division
Manufacturing
1,118
out of 5,508
80th
Major group
Chemicals And Allied Products
441
out of 2,378
82nd
Industry group
Drugs
385
out of 2,099
82nd
Industry
Pharmaceutical Preparations
258
out of 1,549
83rd
Source: SEC filing on April 21, 2022.

Ali-Jackson's colleagues

We found four more compensation records of executives who worked with Kamil Ali-Jackson at Aclaris Therapeutics in 2021.

2021

Neal Walker

Aclaris Therapeutics

Chief Executive Officer

2021

Joseph Monahan

Aclaris Therapeutics

Chief Scientific Officer

2021

Frank Ruffo

Aclaris Therapeutics

Chief Financial Officer

2021

David Gordon

Aclaris Therapeutics

Chief Medical Officer

News

You may also like